Immunocore has struck another cancer R&D pact with one of the world's top drugmakers, signing a deal with Eli Lilly that'll both bring in short-term revenue and help the biotech build value in its proprietary pipeline.
Merck KGaA, in the middle of a reformation plot in its biopharma division, has found a new head of drug R&D, moving on after its last research chief lasted just 6 months in the job.
With antibiotic resistance on the rise at a time when Big Pharma has largely left the risk-heavy field, the President's Council of Advisors on Science and Technology is proposing a number of recommendations to lure companies back into the arena and help speed up the development of new antibiotics.
480 Biomedical won $1 million in Phase II funding from the National Heart, Lung, and Blood Institute (NHLBI) to support development of its self-expanding scaffold for patients with pediatric artery stenosis (PAS).
The tool will allow users to sift through three-dimensional images, such as synapses or neurons, more efficiently and comprehensively than previous technology allowed.
With the porcine epidemic diarrhea virus wiping out some 100,000 piglets a week, animal health company VMRD has developed a diagnostic tool that can be used to detect antibody to the virus.
Chinese clinical research outfit HD Biosciences has struck a deal with Marshall University to collaborate on cancer drug development, sharing costs and risks in hopes of commercializing new therapies.
The 5 most promising antibiotic treatments in the industry's pipeline all have something in common: Not one was developed by Big Pharma.
As the death toll from West Africa's Ebola outbreak hits nearly 540--a 60% mortality rate--drug development for the untreatable disease is lagging, largely due to lack of interest from Big Pharma and the relative infrequency of the disease.
Soon, there will be a device to cure some forgetfulness if the Department of Defense's four-year grant of up to $40 million succeeds in fostering implants and electronic interfaces that diagnose and treat memory loss due to traumatic brain injury.